Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-'Go for it,' says grandmother who got world's first Pfizer COVID vaccine in Britain

Tue, 08th Dec 2020 07:09

* Grandmother, 90, gets Pfizer vaccine

* Britain rolls out COVID vaccine, first in the West

* 'You can do it too' says first recipient
(Adds quotes, details)

By Kate Holton

LONDON, Dec 8 (Reuters) - Margaret Keenan, the 90-year-old
grandmother who became the first person in the world to receive
the Pfizer COVID-19 vaccine outside of a trial in Britain on
Tuesday, has a message for others: "go for it" to beat the
devastating disease.

An early riser, Keenan, from Northern Ireland, received the
Pfizer-BioNTech shot at her local hospital in
Coventry, central England, at 0631 GMT, a week before she turns
91.

A video showed her being wheeled out of the ward while
nursing staff clad in protective gear lined the corridor to
applaud and cheer, an echo of moving video clips released
through the year when COVID-19 survivors left hospital.

"I say go for it, go for it because it's free and it's the
best thing that has ever happened," Keenan told reporters as
cameras flashed and television reporters asked questions.

"If I can do it, well, so can you," she told any doubters.

Known as Maggie to her friends, Keenan said she had stuck by
the rules and spent most of the year on her own as the
"devastating" pandemic took hold.

The vaccine means she can start to look forward to spending
time with her family and friends again.

Britain is the first Western country to start immunising its
population in what has been hailed as a turning point in the
battle to defeat the disease. It is the worst-hit country in
Europe with more than 61,000 deaths.

"I wasn't nervous at all," Keenan said, before discussing
plans for her birthday.

Video footage showed the former jewellery shop assistant
wearing a light blue mask, a grey cardigan and a blue T-shirt
with a penguin in snow and the message "Merry Christmas".

She received the shot in her left arm from nurse May
Parsons, who has worked in Britain's National Health Service
(NHS) for 24 years.

"WE WILL BEAT THIS TOGETHER"

The mass inoculation will fuel hope that the world may be
turning a corner in the fight against a pandemic that has
crushed economies and killed more than 1.5 million.

Parsons said the last few months had been tough, but that
there was now light at the end of the tunnel.

"I'm just glad that I'm able to play a part in this historic
day," said Parsons, originally from the Philippines.

British Health Secretary Matt Hancock and Stephen Powis,
medical director for NHS England, said they had both found it
emotional watching the vaccine programme rollout. Hancock wiped
away tears on live television.

An 86-year-old British woman who will also receive the shot
on Tuesday was choked with emotion as she recounted on the radio
how she had had to grieve for her husband alone after he died
with the disease.

She is looking forward to going to the shops and taking the
bus again.

Britain has ordered 40 million doses of the Pfizer/BioNTech
shot. As each person requires two doses, that is enough to
vaccinate 20 million people in the country of 67 million.

About 800,000 doses are expected to be available within the
first week, with care home residents and carers, the over-80s
and some health service workers the top priority to get them.

Keenan said she hadn't made history before but was very
proud to have played her part. For now, though, she said she
planned to have a little rest.
(Editing by Estelle Shirbon, Guy Faulconbridge and Janet
Lawrence)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.